Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005

Archives of Disease in Childhood

Volumn 93, Issue 10, 2008, Pages 845-850

  Quian, J ^a   Ruttimann R ^b   Romero, C ^a   Dall'Orso, P ^a   Cerisola, A ^a   Breuer, T ^c   Greenberg, M ^c   Verstraeten, T ^c  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b GlaxoSmithKline   (Argentina)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; AGE DISTRIBUTION; AMBULATORY CARE; ARTICLE; CHICKENPOX; CHILD; CHILD HOSPITALIZATION; FEMALE; HERD IMMUNITY; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URUGUAY; VACCINATION;

ADOLESCENT; AGE DISTRIBUTION; AMBULATORY CARE; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; HOSPITALIZATION; HUMANS; INFANT; MASS IMMUNIZATION; POPULATION SURVEILLANCE; URUGUAY;

EID: 53549109726     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.126243     Document Type: Article

References (27)

1. Meyer PA, Seward JF, Jwnaan AO, et al. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182:383-90.
2. Centers for Disease Control and Prevention. Varicella-related deaths among children-United States, 1997. MMWR Morb Mortal Wkly Rep 1998;47:365-8.
3. Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine, J Pediatr 1995;127:518-25.
4. Maurice F, De Bouver JL, Vandevoorde D, et al. Immunogenicity and safety of a live attenuated varicella vaccine {Oka/SB Bio) in healthy children. J Infect Dis 1996 Nov;174(Suppl 3):S324-9.
5. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000;19:916-23.
6. Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001;344:955-60.
7. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA 2000;284(10):1271-9.
8. Passwell J, Hemo B, Levi Y, et al. Use of a computerized data base to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J 2004;23:221-6.
9. Nguyen HO, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination In the United States. N Engl J Med 2005;352(5):450-8.
10. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
11. National Advisory Committee on Immunization (NACI) Update on Varicella Canada Communicable Disease Report 2004;30:1-26.
12. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2005. Epidemiologisches Bulletin 2003;30:1-16.
13. Australian Technical Advisory Group on Immunisation (ATAGI)/National Health and Medical Research Council (NHMRCI. The Australian immuntiation handbook. 8th edn. Canberra: National Health & Medical Research Council, 2003.
14. World Hearth Organization Vaccine Preventable Diseases Monitoring System. http://www.who.int/immunization_monitoring/en/globalsummary/ ScheduleSelect.cfm, 20 February 2008.
15. Chi CY, Wang SM. Lin HC. et al. Complications of varicella infection in children in southern Taiwan. J Microbiol Immunol Infect 2006;39|5):402-7.
16. Hee S. Update in varicella vaccination. Korean J Pediatr 2006:49:229-34
17. Rentier B, Gershon AA, the members of EuroVar, the European Working Group on Varicella. A consensus paper; varicella vaccination of healthy children - a challenge for Europe. Pediatr Infect Dis J 2004;23(5):379-89.
18. Quian JW. An outbreak of varicella despite vaccination. N Engl J Med 2003;348:1405-7.
19. Departamento de Inmunizaciones de Corrosion Honoraria de la Lucha Antituberculosa http://www.sup.org.uy/Vacunas.asp, 20 February 2008.
20. 1996 Census. Institute Nacional de Estadistica. Presidency de la República.
21. Seward J, Galil K, Wharton M. Epidemiology of varicella. In: Arvin A, Gershon A, eds Varicella-Zoster virus. Virology and clinical management. 1st edn, Cambridge: Cambridge University Press, 2000:187-206.
22. Notificación de Varicela por region Sanitaria. Dirección de epidemiologia. Ministerio de Salud Pública de la Provincia de Buenos Aires. 2003.
23. Newman RD, Taylor JA. Reactions of pediatricians to the recommendation for universal varicella vaccination. Arch Pediatr Adolesc Med 1998; 152.792-6.
24. Schaffer SJ, Bruno S. Varicella immunisation practices and the factors that influence them. Arch Pediatr Adolesc Med 1999;153:357-62.
25. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003;70(Suppl 1):S31-7.
26. Thomas SL. Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002;360(9334}:678-82.
27. Centers for Disease Control and Prevention. Prevention of Varicella Recommendations of the Advisory Committee on Immunization Practices (ACIP|. MMWR 2007;56(RR-04):1-40.